Genomic Health, Inc. (NASDAQ:GHDX)

CAPS Rating: 5 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Recs

0
Player Avatar bclan13 (99.14) Submitted: 1/18/2013 4:05:28 PM : Underperform Start Price: $29.52 GHDX Score: +5.11

I don't see ex-US growth and I don't believe in any of the new products.

Featured Broker Partners


Advertisement